78698-8  Liver fibrosis score panel - Serum or Plasma Calculated by HepaScoreLiver fibrosis score panel - Serum or Plasma Calculated by HepaScoreLiver fibrosis score panel: -: Pt: Ser/​Plas: -: Calculated.HepaScore  

PANEL HIERARCHY  (view this panel in the LForms viewer)

  LOINC#   LOINC Name R/O/C  Cardinality  Ex. UCUM Units 
  78698-8   Liver fibrosis score panel - Serum or Plasma Calculated by HepaScoreLiver fibrosis score panel - Serum or Plasma Calculated by HepaScoreLiver fibrosis score panel: -: Pt: Ser/​Plas: -: Calculated.HepaScore    
       1835-8   Alpha-2-Macroglobulin [Mass/​volume] in Serum or PlasmaAlpha-2-Macroglobulin [Mass/​volume] in Serum or PlasmaAlpha-2-Macroglobulin: MCnc: Pt: Ser/​Plas: Qn: O   g/l 
       1975-2   Bilirubin.total [Mass/​volume] in Serum or PlasmaBilirubin.total [Mass/​volume] in Serum or PlasmaBilirubin: MCnc: Pt: Ser/​Plas: Qn: O   mg/dL 
       2324-2   Gamma glutamyl transferase [Enzymatic activity/​volume] in Serum or PlasmaGamma glutamyl transferase [Enzymatic activity/​volume] in Serum or PlasmaGamma glutamyl transferase: CCnc: Pt: Ser/​Plas: Qn: O   U/L 
       12736-5   Hyaluronate [Mass/​volume] in Serum or PlasmaHyaluronate [Mass/​volume] in Serum or PlasmaHyaluronate: MCnc: Pt: Ser/​Plas: Qn: O   ug/mL 
       46098-0   SexSexSex: Type: Pt: ^Patient: Nom: O    
       30525-0   AgeAgeAge: Time: Pt: ^Patient: Qn: O  
       78894-3   Liver fibrosis score in Serum or Plasma Calculated by HepaScoreLiver fibrosis score in Serum or Plasma Calculated by HepaScoreLiver fibrosis score: Score: Pt: Ser/​Plas: Qn: Calculated.HepaScore R   {score} 
 

NAME
  Fully Specified Name: 
Component   Property   Time   System   Scale   Method
Liver fibrosis score panel  Pt  Ser/Plas  Calculated.HepaScore
  Long Common Name:  Liver fibrosis score panel - Serum or Plasma Calculated by HepaScore
  Short Name:  Liver fibr score Pnl SerPl HepaScore
  Display Name:  Liver fibrosis score panel Calculated by HepaScore

BASIC ATTRIBUTES
  Class/Type: PANEL.CHEM/Lab
  Panel Type: Panel
  First Released in Version: 2.54
  Last Updated in Version: 2.54
  Order vs. Obs.: Order
  Status: Active

PARTS

Part Type    Part No.  Part Name   
Component   LP200134-7  Liver fibrosis score panel 
Time   LP6960-1  Pt   [Point in time (spot)] 
System   LP7576-4  Ser/Plas   [Serum or Plasma] 
Scale   LP7747-1 
Method   LP199510-1  Calculated.HepaScore   [Calculated by HepaScore] 
Fragments for synonyms   LP21059-8  Panel 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  肝脏纤维化评分组套:-:时间点:血清/​血浆:-:计算法.HepaScore肝脏纤维化评分组套:-:时间点:血清/​血浆:-:计算法.HepaScore
  French (FRANCE)  (From: ASIP Santé (Agence des systèmes d'information partagés de santé))
 
  Liver fibrosis score panel:-:Pt:Ser/​Plas:-:Calculated.HepaScoreLiver fibrosis score panel:-:Pt:Ser/​Plas:-:Calculated.HepaScoreScore de fibrose du foie panel [-] Sérum/​Plasma ; - ; Calcul par Hepascore
  Italian (ITALY)  (From: Regenstrief-generated full translation based on part translation provided by Consiglio Nazionale delle Ricerche)
 
  Fibrosi epatica, panel punteggio:-:Pt:Siero/​Plasma:-:Calcolato.HepaScoreFibrosi epatica, panel punteggio:-:Pt:Siero/​Plasma:-:Calcolato.HepaScore
  Spanish (SPAIN)  (From: Regenstrief-generated full translation based on part translation provided by the Clinical Laboratory Committee of SERVICIO EXTREMEÑO DE SALUD, with the support of BITAC MAP.)
 
  Panel de puntuación fibrosis hepática:Propiedades mixtas (sólo paneles):Punto temporal:Suero o Plasma:-:Calculado por HepaScorePanel de puntuación fibrosis hepática:Propiedades mixtas (sólo paneles):Punto temporal:Suero o Plasma:-:Calculado por HepaScore

RELATED NAMES
  Calc Panl SerPl
  Calc.HepaScore Pl SerPlas
  Calculation Plasma Serum
  Chemistry Plsm Serum or plasma
  Liver fibr score Pnl SR
  Liver fibr score Pnl Point in time  
  Pan Random  
  PANEL.CHEMISTRY SerP  

CHANGE HISTORY
  Change Type: ADD

INTERNAL FIELDS
  Detail Page Created On: 6/26/2019 2:22:02 PM
  Long Common Name: Liver fibrosis score panel - Serum or Plasma Calculated by HepaScore
  Shortname: Liver fibr score Pnl SerPl HepaScore
  Fully Specified Name: Liver fibrosis score panel: -: Pt: Ser/Plas: -: Calculated.HepaScore
     
  Component Word Count: 4
  ID: 82456
  # of Panel Elements: 8
  Status (Raw): ACTIVE



Selected information about each LOINC that is part of this panel



1835-8   Alpha-2-Macroglobulin [Mass/​volume] in Serum or PlasmaAlpha-2-Macroglobulin [Mass/​volume] in Serum or PlasmaAlpha-2-Macroglobulin: MCnc: Pt: Ser/​Plas: Qn:  

NAME
  Fully Specified Name: 
Component   Property   Time   System   Scale   Method
Alpha-2-Macroglobulin  MCnc  Pt  Ser/Plas  Qn 
  Long Common Name:  Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma
  Short Name:  A2 Macroglob SerPl-mCnc
  Display Name:  Alpha-2-Macroglobulin [Mass/Vol]

PART DEFINITION/DESCRIPTION(S)
  Part: Alpha-2-Macroglobulin
  A protease inhibitor and one of the largest plasma proteins. Increased levels of Alpha-2-Macroglobulin are found in nephrotic syndrome when lower molecular weight proteins are lost and Alpha-2-Macroglobulin is retained because of its large size.
 
 

OBSERVATION REQUIRED IN PANEL
Optional

TYPE OF ENTRY
Question

BASIC ATTRIBUTES
  Class/Type: CHEM/Lab
  First Released in Version: 1.0
  Last Updated in Version: 2.40
  Order vs. Obs.: Both
  Status: Active

MEMBER OF THESE PANELS     
  This section provides information about panels that contain this LOINC code.
  LOINC   Long Common Name  
  48796-7 Hepatitis C virus FibroSURE panel - Serum or Plasma
  78698-8 Liver fibrosis score panel - Serum or Plasma Calculated by HepaScore
  78699-6 Liver fibrosis score panel - Serum or Plasma Calculated by FibroMeter
  

PARTS

Part Type    Part No.  Part Name   
Component   LP15377-2  Alpha-2-Macroglobulin 
Property   LP6827-2  MCnc   [Mass Concentration] 
Time   LP6960-1  Pt   [Point in time (spot)] 
System   LP7576-4  Ser/Plas   [Serum or Plasma] 
Scale   LP7753-9  Qn 
Fragments for synonyms   LP20740-4 
Fragments for synonyms   LP28426-2  Alpha 2 
Fragments for synonyms   LP28489-0  Alpha 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  Alpha-2-巨球蛋白:质量浓度:时间点:血清/​血浆:定量型:Alpha-2-巨球蛋白:质量浓度:时间点:血清/​血浆:定量型:
  Dutch (NETHERLANDS)  (From: Regenstrief-generated full translation based on part translation provided by NVKC, Dutch Society for Clinical Chemistry and Laboratory Medicine, The Netherlands)
 
  alfa-2-macroglobuline:massa/​volume:moment:serum of plasma:kwantitatief:alfa-2-macroglobuline:massa/​volume:moment:serum of plasma:kwantitatief:
  Estonian (ESTONIA)  (From: Regenstrief-generated full translation based on part translation provided by Estonian E-Health Foundation)
 
  Alfa-2-makroglobuliin:MCnc:Pt:S/​P:Qn:Alfa-2-makroglobuliin:MCnc:Pt:S/​P:Qn:
  French (BELGIUM)  (From: Regenstrief-generated full translation based on part translation provided by Jean M. Prevost, MD, Biopathology)
 
  Alpha-2-macroglobuline:Concentration de masse:Temps ponctuel:Sérum/​Plasma:Quantitatif:Alpha-2-macroglobuline:Concentration de masse:Temps ponctuel:Sérum/​Plasma:Quantitatif:
  French (CANADA)  (From: Regenstrief-generated full translation based on part translation provided by Canada Health Infoway Inc.)
 
  Alpha-2-macroglobuline:Concentration de masse:Temps ponctuel:Sérum/​Plasma:Quantitatif:Alpha-2-macroglobuline:Concentration de masse:Temps ponctuel:Sérum/​Plasma:Quantitatif:
  French (FRANCE)  (From: ASIP Santé (Agence des systèmes d'information partagés de santé))
 
  Alpha-2-Macroglobulin:MCnc:Pt:Ser/​Plas:Qn:Alpha-2-Macroglobulin:MCnc:Pt:Ser/​Plas:Qn:Alpha-2 macroglobuline [Masse/​Volume] Sérum/​Plasma ; Numérique
  French (SWITZERLAND)  (From: CUMUL, Switzerland)
 
  S--macroglobuline, alpha 2
  German (AUSTRIA)  (From: ELGA, Austria)
 
  A2-Makroglobulin
  German (GERMANY)  (From: Institute for Medical Documentation and Information (DIMDI))
 
  Alpha-2-Makroglobulin:MKnz:Pkt:Ser/​Plas:Qn:Alpha-2-Makroglobulin:MKnz:Pkt:Ser/​Plas:Qn:
  German (SWITZERLAND)  (From: CUMUL, Switzerland)
 
  S--Makroglobulin, Alpha-2-
  Italian (ITALY)  (From: Regenstrief-generated full translation based on part translation provided by Consiglio Nazionale delle Ricerche)
 
  Alfa-2-Macroglobulina:MCnc:Pt:Siero/​Plasma:Qn:Alfa-2-Macroglobulina:MCnc:Pt:Siero/​Plasma:Qn:
  Italian (SWITZERLAND)  (From: CUMUL, Switzerland)
 
  S--macroglobulina, alfa 2
  Korean (KOREA, REPUBLIC OF)  (From: Korean Ministry for Health, Welfare, and Family Affairs)
 
  알파-2-마크로글로불린:질량농도:검사시점:혈청/​혈장:정량:알파-2-마크로글로불린:질량농도:검사시점:혈청/​혈장:정량:
  Portuguese (BRAZIL)  (From: HL7 Brazil Institute)
 
  Alfa-2-Macroglobulina:MCnc:Pt:Sor/​Plas:Qn:Alfa-2-Macroglobulina:MCnc:Pt:Sor/​Plas:Qn:
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Альфа-2-Макроглобулин:МассКонц:ТчкВрм:Сыв/​Плаз:Колич:Альфа-2-Макроглобулин:МассКонц:ТчкВрм:Сыв/​Плаз:Колич:
  Spanish (ARGENTINA)  (From: Conceptum Medical Terminology Center)
 
  alfa-2-macroglobulina:concentración de masa:punto en el tiempo:suero:cuantitativo:alfa-2-macroglobulina:concentración de masa:punto en el tiempo:suero:cuantitativo:
  Spanish (SPAIN)  (From: Regenstrief-generated full translation based on part translation provided by the Clinical Laboratory Committee of SERVICIO EXTREMEÑO DE SALUD, with the support of BITAC MAP.)
 
  Alfa 2 Macroglobulina:Concentración de masa:Punto temporal:Suero o Plasma:Qn:Alfa 2 Macroglobulina:Concentración de masa:Punto temporal:Suero o Plasma:Qn:
  Spanish (SWITZERLAND)  (From: CUMUL, Switzerland)
 
  S--macroglobulina, alfa 2
  Turkish (TURKEY)  (From: Regenstrief-generated full translation based on part translation provided by LOINC Turkish Translation Group and the Turkish Ministry of Health)
 
  Alfa-2-Makroglobulin:KütlKons:Zmlı:Ser/​Plaz:Kant:Alfa-2-Makroglobulin:KütlKons:Zmlı:Ser/​Plaz:Kant:

RELATED NAMES
  A2 Macroglobulins Quantitative
  A2 Macroglob Mass concentration Random
  Alfa Pl SerP
  AMG Plasma SerPl
  Chemistry Plsm SerPlas
  II Point in time Serum
  Level QNT Serum or plasma
  Macroglob Quan SR
  Macroglobn Quant  

EXAMPLE UNITS
  Unit  Source Type
  g/L  eCHN 
  g/l  EXAMPLE UCUM UNITS 
  mg/dL  REGENSTRIEF 

UNITS (INTERNAL DETAILS)
  Source Type:  eCHN 
  Unit:  g/L 
  Source Type:  EXAMPLE UCUM UNITS 
  Unit:  g/l 
  Source Type:  REGENSTRIEF 
  Unit:  mg/dL 

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 6/26/2019 2:22:02 PM
  Attachment Units Required: Y
  Long Common Name: Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma
  Shortname: A2 Macroglob SerPl-mCnc
  Fully Specified Name: Alpha-2-Macroglobulin: MCnc: Pt: Ser/Plas: Qn:
     
  Component Word Count: 3
  ID: 9228
  Status (Raw): ACTIVE


1975-2   Bilirubin.total [Mass/​volume] in Serum or PlasmaBilirubin.total [Mass/​volume] in Serum or PlasmaBilirubin: MCnc: Pt: Ser/​Plas: Qn:  

NAME
  Fully Specified Name: 
Component   Property   Time   System   Scale   Method
Bilirubin  MCnc  Pt  Ser/Plas  Qn 
  Long Common Name:  Bilirubin.total [Mass/volume] in Serum or Plasma
  Short Name:  Bilirub SerPl-mCnc
  Display Name:  Bilirubin [Mass/Vol]

TERM DEFINITION/DESCRIPTION(S)
  Method can be DIRECT SPECTOPHOTOMETRY, WET CHEMISTRY or DRY SLIDE (TBIL)
 
 

PART DEFINITION/DESCRIPTION(S)
  Part: Bilirubin
  Bilirubin is an orange-yellow pigment produced by the normal breakdown of heme, a component of the hemoglobin found in red blood cells. It is processed by the liver and excreted in bile. Conditions that cause red blood cell breakdown or interfere with liver or bile processing can cause elevated levels of bilirubin. Bilirubin exists in many forms. Non-glucuronidated bilirubin (also called unconjugated or indirect) is the breakdown product of heme and is not water-soluble. Hemolytic anemias, which cause increased red blood cell breakdown, are one cause of elevated non-glucuronidated bilirubin. Glucuronidated bilirubin (also called conjugated) is a water-soluble form of bilirubin that is made in the liver by the addition of sugar molecules to non-glucuronidated bilirubin. Conditions that affect liver function (such as hepatitis, cirrhosis and liver tumors) or physically block the bile ducts (such as gallstones) can cause elevated levels of glucuronidated bilirubin. A third form of bilirubin is that which is bound to albumin, and it is also known as delta bilirubin because it was originally identified based on the unexpected difference between the total bilirubin level and the level of glucuronidated plus non-glucuronidated bilirubin in some patient samples. Prior to the discovery of albumin-bound bilirubin, the term "direct" bilirubin was used as a synonym for glucuronidated bilirubin, but direct bilirubin is actually glucuronidated plus delta bilirubin (bilirubin covalently bound to albumin).
 
 

MAPPING GUIDANCE
  Description: Total bilirubin = direct + indirect
 
 

OBSERVATION REQUIRED IN PANEL
Optional

TYPE OF ENTRY
Question

BASIC ATTRIBUTES
  Class/Type: CHEM/Lab
  CDISC Lab Test: Y
  Common Lab Results Rank: #21
  Common Orders Rank: #221
  First Released in Version: 1.0
  Last Updated in Version: 2.66
  Mass or Substance Property: M
  Order vs. Obs.: Both
  Status: Active

MEMBER OF THESE PANELS     
  This section provides information about panels that contain this LOINC code.
  LOINC   Long Common Name  
  24322-0 Comprehensive metabolic 1998 panel - Serum or Plasma
  24323-8 Comprehensive metabolic 2000 panel - Serum or Plasma
  24324-6 Hepatic function 1996 panel - Serum or Plasma
  24325-3 Hepatic function 2000 panel - Serum or Plasma
  34543-9 Bilirubin direct and total panel [Mass/volume] - Serum or Plasma
  48796-7 Hepatitis C virus FibroSURE panel - Serum or Plasma
  54232-4 Metabolic panel.large animal - Serum or Plasma
  54233-2 Metabolic panel.small animal - Serum or Plasma
  78698-8 Liver fibrosis score panel - Serum or Plasma Calculated by HepaScore
  

MEMBER OF THESE EQUIVALENCE GROUPS
  LG6199-6  Bilirubin|MCnc|Pt|ANYBldSerPl
  LG49848-1  Bilirubin|Pt|Ser/Plas|584.673 g/mole

PARTS

Part Type    Part No.  Part Name   
Component   LP15448-1  Bilirubin 
Property   LP6827-2  MCnc   [Mass Concentration] 
Time   LP6960-1  Pt   [Point in time (spot)] 
System   LP7576-4  Ser/Plas   [Serum or Plasma] 
Scale   LP7753-9  Qn 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  胆红素:质量浓度:时间点:血清/​血浆:定量型:胆红素:质量浓度:时间点:血清/​血浆:定量型:
  Dutch (NETHERLANDS)  (From: Regenstrief-generated full translation based on part translation provided by NVKC, Dutch Society for Clinical Chemistry and Laboratory Medicine, The Netherlands)
 
  bilirubine:massa/​volume:moment:serum of plasma:kwantitatief:bilirubine:massa/​volume:moment:serum of plasma:kwantitatief:
  Estonian (ESTONIA)  (From: Regenstrief-generated full translation based on part translation provided by Estonian E-Health Foundation)
 
  Bilirubiin:MCnc:Pt:S/​P:Qn:Bilirubiin:MCnc:Pt:S/​P:Qn:
  French (BELGIUM)  (From: Regenstrief-generated full translation based on part translation provided by Jean M. Prevost, MD, Biopathology)
 
  Bilirubine:Concentration de masse:Temps ponctuel:Sérum/​Plasma:Quantitatif:Bilirubine:Concentration de masse:Temps ponctuel:Sérum/​Plasma:Quantitatif:
  French (CANADA)  (From: Regenstrief-generated full translation based on part translation provided by Canada Health Infoway Inc.)
 
  Bilirubine:Concentration de masse:Temps ponctuel:Sérum/​Plasma:Quantitatif:Bilirubine:Concentration de masse:Temps ponctuel:Sérum/​Plasma:Quantitatif:
  French (FRANCE)  (From: ASIP Santé (Agence des systèmes d'information partagés de santé))
 
  Bilirubin:MCnc:Pt:Ser/​Plas:Qn:Bilirubin:MCnc:Pt:Ser/​Plas:Qn:Bilirubine [Masse/​Volume] Sérum/​Plasma ; Numérique
  French (SWITZERLAND)  (From: CUMUL, Switzerland)
 
  S--bilirubine
  German (AUSTRIA)  (From: ELGA, Austria)
 
  Bilirubin
  German (GERMANY)  (From: Institute for Medical Documentation and Information (DIMDI))
 
  Bilirubin:MKnz:Pkt:Ser/​Plas:Qn:Bilirubin:MKnz:Pkt:Ser/​Plas:Qn:
  German (SWITZERLAND)  (From: CUMUL, Switzerland)
 
  S--Bilirubin
  Greek (GREECE)  (From: Regenstrief-generated full translation based on part translation provided by Efstratia Kontaxi, MD, MSc, and Evripidis Stefanidis, MD, with technical support from Panagiotis Kontaxis, Diploma of Electrical and Computer Engineering.)
 
  Χολερυθρίνη:Συγκέντρωση μάζας:Χρονική στιγμή:Ορός/​Πλάσμα:Ποσοτική:Χολερυθρίνη:Συγκέντρωση μάζας:Χρονική στιγμή:Ορός/​Πλάσμα:Ποσοτική:
  Italian (ITALY)  (From: Regenstrief-generated full translation based on part translation provided by Consiglio Nazionale delle Ricerche)
 
  Bilirubina:MCnc:Pt:Siero/​Plasma:Qn:Bilirubina:MCnc:Pt:Siero/​Plasma:Qn:
  Italian (SWITZERLAND)  (From: CUMUL, Switzerland)
 
  S--bilirubina
  Korean (KOREA, REPUBLIC OF)  (From: Korean Ministry for Health, Welfare, and Family Affairs)
 
  빌리루빈:질량농도:검사시점:혈청/​혈장:정량:빌리루빈:질량농도:검사시점:혈청/​혈장:정량:
  Portuguese (BRAZIL)  (From: HL7 Brazil Institute)
 
  Bilirrubina:MCnc:Pt:Sor/​Plas:Qn:Bilirrubina:MCnc:Pt:Sor/​Plas:Qn:
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Билирубин:МассКонц:ТчкВрм:Сыв/​Плаз:Колич:Билирубин:МассКонц:ТчкВрм:Сыв/​Плаз:Колич:
  Spanish (ARGENTINA)  (From: Conceptum Medical Terminology Center)
 
  bilirrubina:concentración de masa:punto en el tiempo:suero/​plasma:cuantitativo:bilirrubina:concentración de masa:punto en el tiempo:suero/​plasma:cuantitativo:
  Spanish (SPAIN)  (From: Regenstrief-generated full translation based on part translation provided by the Clinical Laboratory Committee of SERVICIO EXTREMEÑO DE SALUD, with the support of BITAC MAP.)
 
  Bilirrubina:Concentración de masa:Punto temporal:Suero o Plasma:Qn:Bilirrubina:Concentración de masa:Punto temporal:Suero o Plasma:Qn:
  Spanish (SWITZERLAND)  (From: CUMUL, Switzerland)
 
  S--bilirubina
  Turkish (TURKEY)  (From: Regenstrief-generated full translation based on part translation provided by LOINC Turkish Translation Group and the Turkish Ministry of Health)
 
  Bilirubin:KütlKons:Zmlı:Ser/​Plaz:Kant:Bilirubin:KütlKons:Zmlı:Ser/​Plaz:Kant:

RELATED NAMES
  Bili Point in time SerPlas
  Bilirubins QNT Serum
  Chemistry Quan Serum or plasma
  Level Quant SR
  Mass concentration Quantitative TBIL
  Pl Random  
  Plasma SerP  
  Plsm SerPl  

EXAMPLE UNITS
  Unit  Source Type
  mg/dL  EXAMPLE UCUM UNITS 
  mg/dL  REGENSTRIEF 

UNITS (INTERNAL DETAILS)
  Source Type:  EXAMPLE UCUM UNITS 
  Unit:  mg/dL 
  Source Type:  REGENSTRIEF 
  Unit:  mg/dL 

UNITS AND RANGE
  Range  Units Type
  mg/dL:[0.3,1.0]   

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 6/26/2019 2:22:02 PM
  Attachment Units Required: Y
  Long Common Name: Bilirubin.total [Mass/volume] in Serum or Plasma
  Shortname: Bilirub SerPl-mCnc
  Fully Specified Name: Bilirubin: MCnc: Pt: Ser/Plas: Qn:
     
  Component Word Count: 1
  ID: 10638
  Status (Raw): ACTIVE


2324-2   Gamma glutamyl transferase [Enzymatic activity/​volume] in Serum or PlasmaGamma glutamyl transferase [Enzymatic activity/​volume] in Serum or PlasmaGamma glutamyl transferase: CCnc: Pt: Ser/​Plas: Qn:  

NAME
  Fully Specified Name: 
Component   Property   Time   System   Scale   Method
Gamma glutamyl transferase  CCnc  Pt  Ser/Plas  Qn 
  Long Common Name:  Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
  Short Name:  GGT SerPl-cCnc
  Display Name:  Gamma glutamyl transferase [Catalytic activity/Vol]

PART DEFINITION/DESCRIPTION(S)
  Part: Gamma glutamyl transferase
  Gamma glutamyl transferase (GGT or GGTP, or Gamma-GT) is a liver enzyme. It is involved in the transfer of amino acids across the cellular membrane and in glutathione metabolism. GGT is found in high concentrations in the liver, bile ducts and kidney. The enzyme is also present in other tissues, such as the epididymis. Its level in the blood may be tested because if it is elevated this may indicate an abnormality in the liver, though this can be caused by a number of conditions including: congestive heart failure, cholestasis (congestion of the bile ducts), cirrhosis of the liver, necrosis of the liver. Levels of GGT are also increased in chronic and acute alcohol abuse.
  Copyright: Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
 
 

OBSERVATION REQUIRED IN PANEL
Optional

TYPE OF ENTRY
Question

BASIC ATTRIBUTES
  Class/Type: CHEM/Lab
  CDISC Lab Test: Y
  Common Lab Results Rank: #190
  Common SI Lab Results Rank: #190
  Common Orders Rank: #85
  First Released in Version: 1.0
  Last Updated in Version: 2.40
  Order vs. Obs.: Both
  Status: Active

MEMBER OF THESE PANELS     
  This section provides information about panels that contain this LOINC code.
  LOINC   Long Common Name  
  48796-7 Hepatitis C virus FibroSURE panel - Serum or Plasma
  78698-8 Liver fibrosis score panel - Serum or Plasma Calculated by HepaScore
  78699-6 Liver fibrosis score panel - Serum or Plasma Calculated by FibroMeter
  

PARTS

Part Type    Part No.  Part Name   
Component   LP15590-0  Gamma glutamyl transferase 
Property   LP6789-4  CCnc   [Catalytic Concentration] 
Time   LP6960-1  Pt   [Point in time (spot)] 
System   LP7576-4  Ser/Plas   [Serum or Plasma] 
Scale   LP7753-9  Qn 
Fragments for synonyms   LP20760-2  Glutamyl transferase 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  Gamma 谷氨酰转移酶:催化浓度:时间点:血清/​血浆:定量型:Gamma 谷氨酰转移酶:催化浓度:时间点:血清/​血浆:定量型:
  Dutch (NETHERLANDS)  (From: Regenstrief-generated full translation based on part translation provided by NVKC, Dutch Society for Clinical Chemistry and Laboratory Medicine, The Netherlands)
 
  gamma-glutamyltransferase:enzymatische activiteit/​volume:moment:serum of plasma:kwantitatief:gamma-glutamyltransferase:enzymatische activiteit/​volume:moment:serum of plasma:kwantitatief:
  Estonian (ESTONIA)  (From: Regenstrief-generated full translation based on part translation provided by Estonian E-Health Foundation)
 
  Gammaglutamüüli transferaas:CCnc:Pt:S/​P:Qn:Gammaglutamüüli transferaas:CCnc:Pt:S/​P:Qn:
  French (BELGIUM)  (From: Regenstrief-generated full translation based on part translation provided by Jean M. Prevost, MD, Biopathology)
 
  Gamma glutamyl transférase:Concentration catalytique:Temps ponctuel:Sérum/​Plasma:Quantitatif:Gamma glutamyl transférase:Concentration catalytique:Temps ponctuel:Sérum/​Plasma:Quantitatif:
  French (CANADA)  (From: Regenstrief-generated full translation based on part translation provided by Canada Health Infoway Inc.)
 
  Gamma glutamyl transférase:Concentration catalytique:Temps ponctuel:Sérum/​Plasma:Quantitatif:Gamma glutamyl transférase:Concentration catalytique:Temps ponctuel:Sérum/​Plasma:Quantitatif:
  French (FRANCE)  (From: ASIP Santé (Agence des systèmes d'information partagés de santé))
 
  Gamma glutamyl transferase:CCnc:Pt:Ser/​Plas:Qn:Gamma glutamyl transferase:CCnc:Pt:Ser/​Plas:Qn:Gamma glutamyltransférase [Catalytique/​Volume] Sérum/​Plasma ; Numérique
  French (SWITZERLAND)  (From: CUMUL, Switzerland)
 
  S--glutamyltransférase, gamma
  German (AUSTRIA)  (From: ELGA, Austria)
 
  Gamma-GT
  German (GERMANY)  (From: Institute for Medical Documentation and Information (DIMDI))
 
  Gamma-Glutamyl-Transferase:KKnz:Pkt:Ser/​Plas:Qn:Gamma-Glutamyl-Transferase:KKnz:Pkt:Ser/​Plas:Qn:
  German (SWITZERLAND)  (From: CUMUL, Switzerland)
 
  S--Glutamyltransferase, Gamma
  Greek (GREECE)  (From: Regenstrief-generated full translation based on part translation provided by Efstratia Kontaxi, MD, MSc, and Evripidis Stefanidis, MD, with technical support from Panagiotis Kontaxis, Diploma of Electrical and Computer Engineering.)
 
  γ-γλουταμική τρανφεράση:Καταλυτική Συγκέντρωση:Χρονική στιγμή:Ορός/​Πλάσμα:Ποσοτική:γ-γλουταμική τρανφεράση:Καταλυτική Συγκέντρωση:Χρονική στιγμή:Ορός/​Πλάσμα:Ποσοτική:
  Italian (ITALY)  (From: Regenstrief-generated full translation based on part translation provided by Consiglio Nazionale delle Ricerche)
 
  Gamma glutamil transferasi:CCnC:Pt:Siero/​Plasma:Qn:Gamma glutamil transferasi:CCnC:Pt:Siero/​Plasma:Qn:
  Italian (SWITZERLAND)  (From: CUMUL, Switzerland)
 
  S--glutamiltransferasi, gamma
  Korean (KOREA, REPUBLIC OF)  (From: Korean Ministry for Health, Welfare, and Family Affairs)
 
  감마 글루타밀 전이효소:촉매농도:검사시점:혈청/​혈장:정량:감마 글루타밀 전이효소:촉매농도:검사시점:혈청/​혈장:정량:
  Portuguese (BRAZIL)  (From: HL7 Brazil Institute)
 
  Gama Glutamil Transferase:CCnc:Pt:Sor/​Plas:Qn:Gama Glutamil Transferase:CCnc:Pt:Sor/​Plas:Qn:
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Гамма глутамил трансфераза:КаталКонц:ТчкВрм:Сыв/​Плаз:Колич:Гамма глутамил трансфераза:КаталКонц:ТчкВрм:Сыв/​Плаз:Колич:
  Spanish (ARGENTINA)  (From: Conceptum Medical Terminology Center)
 
  gamma glutamiltransferasa:concentración catalítica:punto en el tiempo:suero/​plasma:cuantitativo:gamma glutamiltransferasa:concentración catalítica:punto en el tiempo:suero/​plasma:cuantitativo:
  Spanish (SPAIN)  (From: Regenstrief-generated full translation based on part translation provided by the Clinical Laboratory Committee of SERVICIO EXTREMEÑO DE SALUD, with the support of BITAC MAP.)
 
  Gamma glutamil transferasa:Concentración Catalítica:Punto temporal:Suero o Plasma:Qn:Gamma glutamil transferasa:Concentración Catalítica:Punto temporal:Suero o Plasma:Qn:
  Spanish (SWITZERLAND)  (From: CUMUL, Switzerland)
 
  S--glutamiltransferasa, gamma
  Turkish (TURKEY)  (From: Regenstrief-generated full translation based on part translation provided by LOINC Turkish Translation Group and the Turkish Ministry of Health)
 
  Gamma glutamil transferaz:KtlKons:Zmlı:Ser/​Plaz:Kant:Gamma glutamil transferaz:KtlKons:Zmlı:Ser/​Plaz:Kant:

RELATED NAMES
  Catalytic Concentration Plasma SerP
  Chemistry Plsm SerPl
  Gamma glutamyl transpeptidase Point in time SerPlas
  Gamma-GTP QNT Serum
  GGT Quan Serum or plasma
  GGTP Quant SR
  GT Quantitative  
  Pl Random  

EXAMPLE UNITS
  Unit  Source Type
  U/L  EXAMPLE UCUM UNITS 
  U/L  eCHN 
  units/L  REGENSTRIEF 

UNITS (INTERNAL DETAILS)
  Source Type:  EXAMPLE UCUM UNITS 
  Unit:  U/L 
  Source Type:  eCHN 
  Unit:  U/L 
  Source Type:  REGENSTRIEF 
  Unit:  units/L 

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 6/26/2019 2:22:02 PM
  Attachment Units Required: Y
  Long Common Name: Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
  Shortname: GGT SerPl-cCnc
  Fully Specified Name: Gamma glutamyl transferase: CCnc: Pt: Ser/Plas: Qn:
     
  Component Word Count: 3
  ID: 14486
  Status (Raw): ACTIVE


12736-5   Hyaluronate [Mass/​volume] in Serum or PlasmaHyaluronate [Mass/​volume] in Serum or PlasmaHyaluronate: MCnc: Pt: Ser/​Plas: Qn:  

NAME
  Fully Specified Name: 
Component   Property   Time   System   Scale   Method
Hyaluronate  MCnc  Pt  Ser/Plas  Qn 
  Long Common Name:  Hyaluronate [Mass/volume] in Serum or Plasma
  Short Name:  Hyaluronate SerPl-mCnc
  Display Name:  Hyaluronate [Mass/Vol]

PART DEFINITION/DESCRIPTION(S)
  Part: Hyaluronate
  Hyaluronan (also called hyaluronic acid or hyaluronate or HA) is an anionic, nonsulfated glycosaminoglycan distributed widely throughout connective, epithelial, and neural tissues. It is unique among glycosaminoglycans in that it is nonsulfated, forms in the plasma membrane instead of the Golgi, and can be very large, with its molecular weight often reaching the millions. One of the chief components of the extracellular matrix, hyaluronan contributes significantly to cell proliferation and migration, and may also be involved in the progression of some malignant tumors.

Hyaluronic acid is also a component of the group A streptococcal extracellular capsule,[4] and is believed to play a role in virulence
  Copyright: Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
 
 

OBSERVATION REQUIRED IN PANEL
Optional

BASIC ATTRIBUTES
  Class/Type: DRUG/TOX/Lab
  First Released in Version: 1.0j-a
  Last Updated in Version: 2.40
  Order vs. Obs.: Both
  Status: Active

MEMBER OF THESE PANELS     
  This section provides information about panels that contain this LOINC code.
  LOINC   Long Common Name  
  78698-8 Liver fibrosis score panel - Serum or Plasma Calculated by HepaScore
  

PARTS

Part Type    Part No.  Part Name   
Component   LP18177-3  Hyaluronate 
Property   LP6827-2  MCnc   [Mass Concentration] 
Time   LP6960-1  Pt   [Point in time (spot)] 
System   LP7576-4  Ser/Plas   [Serum or Plasma] 
Scale   LP7753-9  Qn 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  透明质酸:质量浓度:时间点:血清/​血浆:定量型:透明质酸:质量浓度:时间点:血清/​血浆:定量型:
  Dutch (NETHERLANDS)  (From: Regenstrief-generated full translation based on part translation provided by NVKC, Dutch Society for Clinical Chemistry and Laboratory Medicine, The Netherlands)
 
  hyaluronaat:massa/​volume:moment:serum of plasma:kwantitatief:hyaluronaat:massa/​volume:moment:serum of plasma:kwantitatief:
  Estonian (ESTONIA)  (From: Regenstrief-generated full translation based on part translation provided by Estonian E-Health Foundation)
 
  Hüaluronaat:MCnc:Pt:S/​P:Qn:Hüaluronaat:MCnc:Pt:S/​P:Qn:
  French (BELGIUM)  (From: Regenstrief-generated full translation based on part translation provided by Jean M. Prevost, MD, Biopathology)
 
  Hyaluronate:Concentration de masse:Temps ponctuel:Sérum/​Plasma:Quantitatif:Hyaluronate:Concentration de masse:Temps ponctuel:Sérum/​Plasma:Quantitatif:
  French (CANADA)  (From: Regenstrief-generated full translation based on part translation provided by Canada Health Infoway Inc.)
 
  Hyaluronate:Concentration de masse:Temps ponctuel:Sérum/​Plasma:Quantitatif:Hyaluronate:Concentration de masse:Temps ponctuel:Sérum/​Plasma:Quantitatif:
  French (FRANCE)  (From: ASIP Santé (Agence des systèmes d'information partagés de santé))
 
  Hyaluronate:MCnc:Pt:Ser/​Plas:Qn:Hyaluronate:MCnc:Pt:Ser/​Plas:Qn:Hyaluronate [Masse/​Volume] Sérum/​Plasma ; Numérique
  French (SWITZERLAND)  (From: CUMUL, Switzerland)
 
  S--hyaluronate
  German (AUSTRIA)  (From: ELGA, Austria)
 
  Hyaluronsäure
  German (GERMANY)  (From: Institute for Medical Documentation and Information (DIMDI))
 
  Hyaluronat:MKnz:Pkt:Ser/​Plas:Qn:Hyaluronat:MKnz:Pkt:Ser/​Plas:Qn:
  German (SWITZERLAND)  (From: CUMUL, Switzerland)
 
  S--Hyaluronat
  Italian (ITALY)  (From: Regenstrief-generated full translation based on part translation provided by Consiglio Nazionale delle Ricerche)
 
  Ialuronato:MCnc:Pt:Siero/​Plasma:Qn:Ialuronato:MCnc:Pt:Siero/​Plasma:Qn:
  Italian (SWITZERLAND)  (From: CUMUL, Switzerland)
 
  S--ialuronato
  Korean (KOREA, REPUBLIC OF)  (From: Korean Ministry for Health, Welfare, and Family Affairs)
 
  히알루론산:질량농도:검사시점:혈청/​혈장:정량:히알루론산:질량농도:검사시점:혈청/​혈장:정량:
  Portuguese (BRAZIL)  (From: HL7 Brazil Institute)
 
  Hialuronato:MCnc:Pt:Sor/​Plas:Qn:Hialuronato:MCnc:Pt:Sor/​Plas:Qn:
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Гиалуронат:МассКонц:ТчкВрм:Сыв/​Плаз:Колич:Гиалуронат:МассКонц:ТчкВрм:Сыв/​Плаз:Колич:
  Spanish (ARGENTINA)  (From: Conceptum Medical Terminology Center)
 
  hialuronato:concentración de masa:punto en el tiempo:suero/​plasma:cuantitativo:hialuronato:concentración de masa:punto en el tiempo:suero/​plasma:cuantitativo:
  Spanish (SPAIN)  (From: Regenstrief-generated full translation based on part translation provided by the Clinical Laboratory Committee of SERVICIO EXTREMEÑO DE SALUD, with the support of BITAC MAP.)
 
  Hialuronato:Concentración de masa:Punto temporal:Suero o Plasma:Qn:Hialuronato:Concentración de masa:Punto temporal:Suero o Plasma:Qn:
  Spanish (SWITZERLAND)  (From: CUMUL, Switzerland)
 
  S--hialuronato
  Turkish (TURKEY)  (From: Regenstrief-generated full translation based on part translation provided by LOINC Turkish Translation Group and the Turkish Ministry of Health)
 
  Hyalüronat:KütlKons:Zmlı:Ser/​Plaz:Kant:Hyalüronat:KütlKons:Zmlı:Ser/​Plaz:Kant:

RELATED NAMES
  DRUG/TOXICOLOGY Plasma SerP
  Drugs Plsm SerPl
  HA Point in time SerPlas
  Hyaluronan QNT Serum
  Hyaluronic acid Quan Serum or plasma
  Level Quant SR
  Mass concentration Quantitative  
  Pl Random  

EXAMPLE UNITS
  Unit  Source Type
  ug/mL  EXAMPLE UCUM UNITS 

UNITS (INTERNAL DETAILS)
  Source Type:  EXAMPLE UCUM UNITS 
  Unit:  ug/mL 

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 6/26/2019 2:22:02 PM
  Attachment Units Required: Y
  Long Common Name: Hyaluronate [Mass/volume] in Serum or Plasma
  Shortname: Hyaluronate SerPl-mCnc
  Fully Specified Name: Hyaluronate: MCnc: Pt: Ser/Plas: Qn:
     
  Component Word Count: 1
  ID: 3032
  Status (Raw): ACTIVE


46098-0   SexSexSex: Type: Pt: ^Patient: Nom:  

NAME
  Fully Specified Name: 
Component   Property   Time   System   Scale   Method
Sex  Type  Pt  ^Patient  Nom 
  Long Common Name:  Sex
  Short Name:  Sex

PART DEFINITION/DESCRIPTION(S)
  Part: Sex
  In LOINC, sex refers to the biological sex of an organism, which is most commonly determined based on anatomy and physiology or genetic (chromosome) analysis. Our definition is based on the World Health Organization's definition of sex and gender: sex (male, female) refers to biological and physiological characteristics, and gender (masculine, feminine) refers to socially constructed roles, behaviors, activities, and attributes. (http://www.who.int/gender/whatisgender/en)
 
 

OBSERVATION REQUIRED IN PANEL
Optional

BASIC ATTRIBUTES
  Class/Type: ADMIN.PATIENT.DEMOG/Clinical
  First Released in Version: 2.17
  Last Updated in Version: 2.66
  Order vs. Obs.: Both
  Status: Active.
Change Reason: Changed Component from 'Gender' to 'Sex' to align with the World Health Organization (WHO) definition of this concept.

HL7 ATTRIBUTES
  HL7 Field ID: PID-8

EXAMPLE ANSWER LIST    (LL1-9)  
 
Source: Regenstrief LOINC
  SEQ#        Answer        Code         Answer ID    
  1       Male       1       LA2-8  
  2       Female       2       LA3-6  

MEMBER OF THESE PANELS     
  This section provides information about panels that contain this LOINC code and, if applicable, override LOINC answer lists that are associated with this LOINC term in the context of that panel. Override lists are used when the panel requires a different answer list and/or answer list link type than the default answer list associated with this LOINC.
  LOINC   Long Common Name   Answer List Id Answer List Type   # of answers
  45963-6 MDS basic assessment tracking form - version 2.0
  46462-8 Outcome and assessment information set (OASIS) form - version B1
  47245-6 HIV treatment form Document
  52743-2 Continuity Assessment Record and Evaluation (CARE) tool - Acute Care
  52744-0 Continuity Assessment Record and Evaluation (CARE) tool - Post Acute Care (PAC) - Admission
  52745-7 Continuity Assessment Record and Evaluation (CARE) tool - Post Acute Care (PAC) - Discharge
  52746-5 Continuity Assessment Record and Evaluation (CARE) tool - Interim
  52747-3 Continuity Assessment Record and Evaluation (CARE) tool - Expired
  52748-1 Continuity Assessment Record and Evaluation (CARE) tool - Home Health Admission
  54580-6 Minimum Data Set - version 3.0
  55140-8 Vaccine Adverse Event Reporting System (VAERS) panel
  55168-9 Data Elements for Emergency Department Systems (DEEDS) Release 1.1
  57039-0 Outcome and assessment information set (OASIS) form - version C
  57190-1 Outcome and assessment information set (OASIS) form - version C - Start of care
  61129-3 PhenX domain - Demographics
  62263-9 PhenX domain - Nutrition and dietary supplements
  62611-9 PhenX domain - Respiratory
  62755-4 PhenX domain - Neurology
  62787-7 PhenX domain - Diabetes
  62812-3 PhenX domain - Physical activity and physical fitness
  62863-6 PhenX domain - Infectious diseases and immunity
  63009-5 PhenX domain - Social environments
  63067-3 PhenX domain - Speech and hearing
  67868-0 End Stage Renal Disease (ESRD) Medical Evidence Report, Medicare Entitlement AndOr Patient Registration - OMB CMS form 2728
  68359-9 End Stage Renal Disease (ESRD) Death Notification - OMB CMS form 2746
  69412-5 Continuity Assessment Record and Evaluation (CARE) tool - Long term care hospital (LTCH) - version 1.0
  69723-5 Patient Health Questionnaire (PHQ) [Reported]
  69919-9 Race, ethnicity, sex, primary language, disability - Health and Human Services (HHS) panel [HHS.ACA Section 4302]
  70297-7 ESRD patient information panel
  78698-8 Liver fibrosis score panel - Serum or Plasma Calculated by HepaScore
  78699-6 Liver fibrosis score panel - Serum or Plasma Calculated by FibroMeter
  82259-3 Metabolic equivalent of task and Resting metabolic rate panel
  82287-4 Physical activity panel
  83265-9 Inpatient Rehabilitation Facility - Patient Assessment Instrument (IRF-PAI) - version 1.4 [CMS Assessment]
  85626-0 Kidney failure 2-year and 5-year risk panel by KFRE
  85645-0 Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Admission - version 3.00 [CMS Assessment]
  85662-5 Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Planned Discharge - version 3.00 [CMS Assessment]
  85668-2 Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Unplanned Discharge - version 3.00 [CMS Assessment]
  85671-6 Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Expired - version 3.00 [CMS Assessment]
  85907-4 Outcome and assessment information set (OASIS) form - version C2 - Start of care [CMS Assessment]
  86522-0 MDS v3.0 - RAI v1.14.1 - Nursing home comprehensive (NC) item set [CMS Assessment]
  86636-8 Family planning report - FPAR 2.0 set
  86856-2 MDS v3.0 - RAI v1.14.1 - Nursing home PPS (NP) and Nursing home quarterly (NQ) item set [CMS Assessment]
  86870-3 MDS v3.0 - RAI v1.14.1 - Nursing home and Swing bed OMRA (NO/SO) item set [CMS Assessment]
  86871-1 MDS v3.0 - RAI v1.14.1 - Nursing home OMRA start of therapy and discharge (NSD) and Swing bed OMRA start of therapy and discharge (SSD) item set [CMS Assessment]
  86872-9 MDS v3.0 - RAI v1.14.1 - Nursing home discharge (ND) and Swing bed discharge (SD) item set [CMS Assessment]
  86873-7 MDS v3.0 - RAI v1.14.1 - Nursing home OMRA-discharge (NOD) and Swing bed OMRA-discharge (SOD) item set [CMS Assessment]
  86874-5 MDS v3.0 - RAI v1.14.1 - Nursing home and Swing bed OMRA start of therapy (NS/SS) item set [CMS Assessment]
  86875-2 MDS v3.0 - RAI v1.14.1 - Nursing home and Swing bed tracking (NT/ST) item set [CMS Assessment]
  86876-0 MDS v3.0 - RAI v1.14.1 - Swing bed PPS (SP) item set [CMS Assessment]
  86877-8 MDS v3.0 - RAI v1.14.1 - Nursing home part A PPS discharge (NPE) item set [CMS Assessment]
  87414-9 Inpatient Rehabilitation Facility - Patient Assessment Instrument (IRF-PAI) - version 1.5 [CMS Assessment]
  87506-2 Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Expired - version 4.00 [CMS Assessment]
  87507-0 Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Planned Discharge - version 4.00 [CMS Assessment]
  87508-8 Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Unplanned Discharge - version 4.00 [CMS Assessment]
  87509-6 Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Admission - version 4.00 [CMS Assessment]
  88279-5 MDS v3.0 - RAI v1.15.1 - Nursing home and Swing bed OMRA (NO and SO) item set [CMS Assessment]
  88280-3 MDS v3.0 - RAI v1.15.1 - Nursing home and Swing bed OMRA start of therapy (NS and SS) item set [CMS Assessment]
  88281-1 MDS v3.0 - RAI v1.15.1 - Nursing home and Swing bed tracking (NT and ST) item set [CMS Assessment]
  88282-9 MDS v3.0 - RAI v1.15.1 - Nursing home comprehensive (NC) item set [CMS Assessment]
  88283-7 MDS v3.0 - RAI v1.15.1 - Nursing home discharge (ND) and Swing bed discharge (SD) item set [CMS Assessment]
  88284-5 MDS v3.0 - RAI v1.15.1 - Nursing home OMRA start of therapy and discharge (NSD) and Swing bed OMRA start of therapy and discharge (SSD) item set [CMS Assessment]
  88285-2 MDS v3.0 - RAI v1.15.1 - Nursing home OMRA-discharge (NOD) and Swing bed OMRA-discharge (SOD) item set [CMS Assessment]
  88286-0 MDS v3.0 - RAI v1.15.1 - Nursing home part A PPS discharge (NPE) item set [CMS Assessment]
  88287-8 MDS v3.0 - RAI v1.15.1 - Nursing home PPS (NP) item set [CMS Assessment]
  88288-6 MDS v3.0 - RAI v1.15.1 - Swing bed PPS (SP) item set [CMS Assessment]
  88292-8 MDS v3.0 - RAI v1.15.1 - Nursing home quarterly (NQ) item set [CMS Assessment]
  88329-8 Inpatient Rehabilitation Facility - Patient Assessment Instrument (IRF-PAI) - version 2.0 [CMS Assessment]
  88373-6 Outcome and assessment information set (OASIS) form - version D - Start of care [CMS Assessment]
  88945-1 MDS v3.0 - RAI v1.16.1 - Nursing home discharge (ND) and Swing bed discharge (SD) item set [CMS Assessment]
  88946-9 MDS v3.0 - RAI v1.16.1 - Nursing home OMRA start of therapy and discharge (NSD) and Swing bed OMRA start of therapy and discharge (SSD) item set [CMS Assessment]
  88947-7 MDS v3.0 - RAI v1.16.1 - Nursing home OMRA-discharge (NOD) and Swing bed OMRA-discharge (SOD) item set [CMS Assessment]
  88948-5 MDS v3.0 - RAI v1.16.1 - Nursing home part A PPS discharge (NPE) item set [CMS Assessment]
  88949-3 MDS v3.0 - RAI v1.16.1 - Nursing home PPS (NP) item set [CMS Assessment]
  88950-1 MDS v3.0 - RAI v1.16.1 - Swing bed PPS (SP) item set [CMS Assessment]
  88951-9 MDS v3.0 - RAI v1.16.1 - Nursing home and Swing bed OMRA (NO and SO) item set [CMS Assessment]
  88952-7 MDS v3.0 - RAI v1.16.1 - Nursing home and Swing bed OMRA start of therapy (NS and SS) item set [CMS Assessment]
  88953-5 MDS v3.0 - RAI v1.16.1 - Nursing home and Swing bed tracking (NT and ST) item set [CMS Assessment]
  88954-3 MDS v3.0 - RAI v1.16.1 - Nursing home comprehensive (NC) item set [CMS Assessment]
  88955-0 MDS v3.0 - RAI v1.16.1 - Nursing home quarterly (NQ) item set [CMS Assessment]
  89070-7 ADAPTABLE patient reported item set [ADAPTABLE]
  89724-9 Minimum Data Set (MDS) for Public Health Emergency Operations Centers (EOC) [CDC Emergency Operations Centers]
  89963-3 Inpatient Rehabilitation Facility - Patient Assessment Instrument (IRF-PAI) - version 3.0 [CMS Assessment] LL1-9 NORMATIVE 2
  90473-0 MDS v3.0 - RAI v1.17.1 - Nursing home comprehensive (NC) item set [CMS Assessment]
  90474-8 MDS v3.0 - RAI v1.17.1 - Nursing home PPS (NP) item set [CMS Assessment]
  90475-5 MDS v3.0 - RAI v1.17.1 - Nursing home quarterly (NQ) item set [CMS Assessment]
  90476-3 MDS v3.0 - RAI v1.17.1 - Swing bed PPS (SP) item set [CMS Assessment]
  90477-1 MDS v3.0 - RAI v1.17.1 - Nursing home discharge (ND) item set [CMS Assessment]
  90478-9 MDS v3.0 - RAI v1.17.1 - Nursing home part A PPS discharge (NPE) item set [CMS Assessment]
  90479-7 MDS v3.0 - RAI v1.17.1 - Nursing home and Swing bed tracking (NT and ST) item set [CMS Assessment]
  90480-5 MDS v3.0 - RAI v1.17.1 - Interim Payment Assessment (IPA) item set [CMS Assessment]
  90481-3 MDS v3.0 - RAI v1.17.1 - Optional State Assessment (OSA) item set [CMS Assessment]
  91393-9 Opioid risk tool panel
  91552-0 MDS v3.0 - RAI v1.17.1 - Swing bed discharge (SD) item set [CMS Assessment]
  

PARTS

Part Type    Part No.  Part Name   
Component   LP101395-4  Sex 
Property   LP6886-8  Type 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7750-5  Nom 
Fragments for synonyms   LP345158-2  Sex 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  性别:类型:时间点:^患者:名义型:性别:类型:时间点:^患者:名义型:
  Dutch (NETHERLANDS)  (From: Regenstrief-generated full translation based on part translation provided by NVKC, Dutch Society for Clinical Chemistry and Laboratory Medicine, The Netherlands)
 
  geslacht:type:moment:^patiënt:nominaal:geslacht:type:moment:^patiënt:nominaal:
  Estonian (ESTONIA)  (From: Regenstrief-generated full translation based on part translation provided by Estonian E-Health Foundation)
 
  Sugu:Tüüp:Pt:^patsient:Nom:Sugu:Tüüp:Pt:^patsient:Nom:
  French (BELGIUM)  (From: Regenstrief-generated full translation based on part translation provided by Jean M. Prevost, MD, Biopathology)
 
  Sexe:Type:Temps ponctuel:^Patient:Nominal:Sexe:Type:Temps ponctuel:^Patient:Nominal:
  French (CANADA)  (From: Regenstrief-generated full translation based on part translation provided by Canada Health Infoway Inc.)
 
  Sexe:Type:Temps ponctuel:^Patient:Nominal:Sexe:Type:Temps ponctuel:^Patient:Nominal:
  Italian (ITALY)  (From: Regenstrief-generated full translation based on part translation provided by Consiglio Nazionale delle Ricerche)
 
  Sesso:Tipo:Pt:^Paziente:Nom:Sesso:Tipo:Pt:^Paziente:Nom:
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Пол:Тип:ТчкВрм:^Пациент:Ном:Пол:Тип:ТчкВрм:^Пациент:Ном:
  Spanish (SPAIN)  (From: Regenstrief-generated full translation based on part translation provided by the Clinical Laboratory Committee of SERVICIO EXTREMEÑO DE SALUD, with the support of BITAC MAP.)
 
  Sexo:Tipo:Punto temporal:^paciente:Nom:Sexo:Tipo:Punto temporal:^paciente:Nom:
  Turkish (TURKEY)  (From: Regenstrief-generated full translation based on part translation provided by LOINC Turkish Translation Group and the Turkish Ministry of Health)
 
  Cinsiyet:Tip:Zmlı:^Hasta:Snf:Cinsiyet:Tip:Zmlı:^Hasta:Snf:

RELATED NAMES
  ADMIN Gender Random
  ADMIN.PATIENT Nominal Typ
  ADMIN.PT.DEMOG Point in time  

RELATED CODES
Code System Code Code Text Code Version
   CMS IRF-PAI   8     3.0 
   CMS IRF-PAI   8     1.4 
   CMS IRF-PAI   8     1.5 
   CMS IRF-PAI   8     2.0 
   CMS LCDS   A0800     4.00 
   CMS LCDS   A0800     3.00 
   CMS MDS   A0800     1.16.1 
   CMS MDS   A0800     1.15.1 
   CMS MDS   A0800     1.17.1 
   CMS MDS   A0800     1.14.1 
   CMS MDS   X0300     1.17.1 
   CMS MDS   X0300     1.14.1 
   CMS MDS   X0300     1.16.1 
   CMS MDS   X0300     1.15.1 
   CMS OASIS   M0069     C2 
   CMS OASIS   M0069     D 
   https://www.phenxtoolkit.org   PX070601010100   PX070601_Self_Gender   
   https://www.phenxtoolkit.org   PX091501010400   PX091501_Sleep_Apnea_Gender   
   https://www.phenxtoolkit.org   PX091502040000   PX091502_Child_Gender   
   https://www.phenxtoolkit.org   PX091601390000   PX091601_Sex   
   https://www.phenxtoolkit.org   PX130501020200   PX130501_Gender   
   https://www.phenxtoolkit.org   PX140201010100   PX140201_Spouse_Sex   
   https://www.phenxtoolkit.org   PX150101020000   PX150101_Sex   
   https://www.phenxtoolkit.org   PX150102010000   PX150102_Sex   
   https://www.phenxtoolkit.org   PX150201020000   PX150201_Gender   
   https://www.phenxtoolkit.org   PX150202020000   PX150202_Gender   
   https://www.phenxtoolkit.org   PX150203010000   PX150203_Gender   
   https://www.phenxtoolkit.org   PX161201010000   PX161201_Gender   
   https://www.phenxtoolkit.org   PX201501170101   PX201501_Sibling1_Sex   
   https://www.phenxtoolkit.org   PX201501170104   PX201501_Sibling1_Cause_Of_Hearing_Difficulty   
   https://www.phenxtoolkit.org   PX201501170203   PX201501_Sibling2_Age_Onset_Hearing_Difficulty   
   https://www.phenxtoolkit.org   PX201501170302   PX201501_Sibling3_Birth_Year   
   https://www.phenxtoolkit.org   PX201501170401   PX201501_Sibling4_Sex   
   https://www.phenxtoolkit.org   PX211101010400   PX211101_Person1_Gender   
   https://www.phenxtoolkit.org   PX211101020400   PX211101_Person2_Gender   
   https://www.phenxtoolkit.org   PX211101030400   PX211101_Person3_Gender   
   https://www.phenxtoolkit.org   PX211101040400   PX211101_Person4_Gender   
   https://www.phenxtoolkit.org   PX211101050400   PX211101_Person5_Gender   
   https://www.phenxtoolkit.org   PX211101060400   PX211101_Person6_Gender   
   https://www.phenxtoolkit.org   PX211101070400   PX211101_Person7_Gender   
   https://www.phenxtoolkit.org   PX211101080400   PX211101_Person8_Gender   
   https://www.phenxtoolkit.org   PX211101090400   PX211101_Person9_Gender   
   https://www.phenxtoolkit.org   PX211101100400   PX211101_Person10_Gender   
   https://www.phenxtoolkit.org   PX211101110400   PX211101_Person11_Gender   
   https://www.phenxtoolkit.org   PX211101120400   PX211101_Person12_Gender   
   https://www.phenxtoolkit.org   PX211101130400   PX211101_Person13_Gender   
   https://www.phenxtoolkit.org   PX211101140400   PX211101_Person14_Gender   
   https://www.phenxtoolkit.org   PX211101150400   PX211101_Person15_Gender   
   https://www.phenxtoolkit.org   PX211101160400   PX211101_Person16_Gender   
   https://www.phenxtoolkit.org   PX211101170400   PX211101_Person17_Gender   
   https://www.phenxtoolkit.org   PX211101180400   PX211101_Person18_Gender   
   https://www.phenxtoolkit.org   PX211101190400   PX211101_Person19_Gender   
   https://www.phenxtoolkit.org   PX211101200400   PX211101_Person20_Gender   

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 6/26/2019 2:22:02 PM
  Attachment Units Required: N
  Long Common Name: Sex
  Shortname: Sex
  Fully Specified Name: Sex: Type: Pt: ^Patient: Nom:
     
  Component Word Count: 1
  ID: 39502
  Status (Raw): ACTIVE


30525-0   AgeAgeAge: Time: Pt: ^Patient: Qn:  

NAME
  Fully Specified Name: 
Component   Property   Time   System   Scale   Method
Age  Time  Pt  ^Patient  Qn 
  Long Common Name:  Age
  Short Name:  Age
  Display Name:  Age [Time]

OBSERVATION REQUIRED IN PANEL
Optional

BASIC ATTRIBUTES
  Class/Type: MISC/Lab
  Common Lab Results Rank: #1575
  Common SI Lab Results Rank: #1575
  First Released in Version: 2.04
  Last Updated in Version: 2.40
  Order vs. Obs.: Observation
  Status: Active

MEMBER OF THESE PANELS     
  This section provides information about panels that contain this LOINC code.
  LOINC   Long Common Name  
  35086-8 Second trimester triple maternal screen panel - Serum or Plasma
  48798-3 First trimester maternal screen panel - Serum or Plasma
  48799-1 Second trimester penta maternal screen panel - Serum or Plasma
  48800-7 Second trimester quad maternal screen panel - Serum or Plasma
  48802-3 Alpha-1-Fetoprotein panel - Serum or Plasma
  49085-4 First and Second trimester integrated maternal screen panel
  49086-2 First trimester maternal screen with nuchal translucency panel
  49087-0 Maternal screen clinical predictors panel
  55140-8 Vaccine Adverse Event Reporting System (VAERS) panel
  58735-2 Alpha-1-Fetoprotein panel - Amniotic fluid
  60687-1 Test of Infant Motor Performance Version 5.1
  62611-9 PhenX domain - Respiratory
  62710-9 PhenX domain - Psychiatric
  62755-4 PhenX domain - Neurology
  62812-3 PhenX domain - Physical activity and physical fitness
  62863-6 PhenX domain - Infectious diseases and immunity
  63009-5 PhenX domain - Social environments
  68991-9 Epidemiologically important information for public health reporting panel
  78698-8 Liver fibrosis score panel - Serum or Plasma Calculated by HepaScore
  78699-6 Liver fibrosis score panel - Serum or Plasma Calculated by FibroMeter
  82259-3 Metabolic equivalent of task and Resting metabolic rate panel
  82287-4 Physical activity panel
  84429-0 Level 3 emergency medical services patient care report - recommended CDA R1 and R2 set
  87825-6 National Trauma Data Standard - version 2018 set
  89543-3 Laboratory ask at order entry panel
  89544-1 Pulmonary Embolism Rule-out Criteria panel PERC
  89549-0 Revised Geneva Score panel
  89694-4 Pulmonary Embolism Severity Index panel [PESI]
  89724-9 Minimum Data Set (MDS) for Public Health Emergency Operations Centers (EOC) [CDC Emergency Operations Centers]
  91393-9 Opioid risk tool panel
  

PARTS

Part Type    Part No.  Part Name   
Component   LP28815-6  Age 
Property   LP6879-3  Time   [Time (e.g. seconds)] 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7753-9  Qn 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  年龄:时间:时间点:^患者:定量型:年龄:时间:时间点:^患者:定量型:
  Dutch (NETHERLANDS)  (From: Regenstrief-generated full translation based on part translation provided by NVKC, Dutch Society for Clinical Chemistry and Laboratory Medicine, The Netherlands)
 
  leeftijd:tijd:moment:^patiënt:kwantitatief:leeftijd:tijd:moment:^patiënt:kwantitatief:
  Estonian (ESTONIA)  (From: Regenstrief-generated full translation based on part translation provided by Estonian E-Health Foundation)
 
  Vanus:Aeg:Pt:^patsient:Qn:Vanus:Aeg:Pt:^patsient:Qn:
  French (BELGIUM)  (From: Regenstrief-generated full translation based on part translation provided by Jean M. Prevost, MD, Biopathology)
 
  Âge:Durée:Temps ponctuel:^Patient:Quantitatif:Âge:Durée:Temps ponctuel:^Patient:Quantitatif:
  French (CANADA)  (From: Regenstrief-generated full translation based on part translation provided by Canada Health Infoway Inc.)
 
  Âge:Durée:Temps ponctuel:^Patient:Quantitatif:Âge:Durée:Temps ponctuel:^Patient:Quantitatif:
  French (FRANCE)  (From: ASIP Santé (Agence des systèmes d'information partagés de santé))
 
  Age:Time:Pt:^Patient:Qn:Age:Time:Pt:^Patient:Qn:Âge [Temps] Patient ; Numérique
  German (GERMANY)  (From: Institute for Medical Documentation and Information (DIMDI))
 
  Alter:Zeit:Pkt:^Patient:Qn:Alter:Zeit:Pkt:^Patient:Qn:
  Italian (ITALY)  (From: Regenstrief-generated full translation based on part translation provided by Consiglio Nazionale delle Ricerche)
 
  Età:Tempo:Pt:^Paziente:Qn:Età:Tempo:Pt:^Paziente:Qn:
  Portuguese (BRAZIL)  (From: HL7 Brazil Institute)
 
  Idade:Tempo:Pt:^Paciente:Qn:Idade:Tempo:Pt:^Paciente:Qn:
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Возраст:Время:ТчкВрм:^Пациент:Колич:Возраст:Время:ТчкВрм:^Пациент:Колич:
  Spanish (ARGENTINA)  (From: Conceptum Medical Terminology Center)
 
  edad:tiempo:punto en el tiempo:^paciente:cuantitativo:edad:tiempo:punto en el tiempo:^paciente:cuantitativo:
  Spanish (SPAIN)  (From: Regenstrief-generated full translation based on part translation provided by the Clinical Laboratory Committee of SERVICIO EXTREMEÑO DE SALUD, with the support of BITAC MAP.)
 
  Edad:Tiempo:Punto temporal:^paciente:Qn:Edad:Tiempo:Punto temporal:^paciente:Qn:
  Turkish (TURKEY)  (From: Regenstrief-generated full translation based on part translation provided by LOINC Turkish Translation Group and the Turkish Ministry of Health)
 
  Yaş:Süre:Zmlı:^Hasta:Kant:Yaş:Süre:Zmlı:^Hasta:Kant:

RELATED NAMES
  MISC Quan Random
  Point in time Quant  
  QNT Quantitative  

EXAMPLE UNITS
  Unit  Source Type
  EXAMPLE UCUM UNITS 

UNITS (INTERNAL DETAILS)
  Source Type:  EXAMPLE UCUM UNITS 
  Unit: 

RELATED CODES
Code System Code Code Text Code Version
   https://www.phenxtoolkit.org   PX091601360000   PX091601_Age   
   https://www.phenxtoolkit.org   PX120602230000   PX120602_EDDS5_Age   
   https://www.phenxtoolkit.org   PX120701030000   PX120701_Age   
   https://www.phenxtoolkit.org   PX130501020100   PX130501_Current_Age   
   https://www.phenxtoolkit.org   PX130601010400   PX130601_Head_Or_Neck_Injury_Age   
   https://www.phenxtoolkit.org   PX130601020400   PX130601_Moving_Vehicle_Head_Injury_Age   
   https://www.phenxtoolkit.org   PX130601030400   PX130601_Fall_Head_Injury_Age   
   https://www.phenxtoolkit.org   PX130601040400   PX130601_Fight_Head_Injury_Age   
   https://www.phenxtoolkit.org   PX130601050400   PX130601_Explosion_Head_Injury_Age   
   https://www.phenxtoolkit.org   PX150101030000   PX150101_Age   
   https://www.phenxtoolkit.org   PX150102020000   PX150102_Age   
   https://www.phenxtoolkit.org   PX150203020000   PX150203_Age   
   https://www.phenxtoolkit.org   PX151401010000   PX151401_Age   
   https://www.phenxtoolkit.org   PX161201020000   PX161201_Age   
   https://www.phenxtoolkit.org   PX161601040101   PX161601_Chicken_Pox_Age   
   https://www.phenxtoolkit.org   PX211101010500   PX211101_Person1_Age   
   https://www.phenxtoolkit.org   PX211101020500   PX211101_Person2_Age   
   https://www.phenxtoolkit.org   PX211101030500   PX211101_Person3_Age   
   https://www.phenxtoolkit.org   PX211101040500   PX211101_Person4_Age   
   https://www.phenxtoolkit.org   PX211101050500   PX211101_Person5_Age   
   https://www.phenxtoolkit.org   PX211101060500   PX211101_Person6_Age   
   https://www.phenxtoolkit.org   PX211101070500   PX211101_Person7_Age   
   https://www.phenxtoolkit.org   PX211101080500   PX211101_Person8_Age   
   https://www.phenxtoolkit.org   PX211101090500   PX211101_Person9_Age   
   https://www.phenxtoolkit.org   PX211101100500   PX211101_Person10_Age   
   https://www.phenxtoolkit.org   PX211101110500   PX211101_Person11_Age   
   https://www.phenxtoolkit.org   PX211101120500   PX211101_Person12_Age   
   https://www.phenxtoolkit.org   PX211101130500   PX211101_Person13_Age   
   https://www.phenxtoolkit.org   PX211101140500   PX211101_Person14_Age   
   https://www.phenxtoolkit.org   PX211101150500   PX211101_Person15_Age   
   https://www.phenxtoolkit.org   PX211101160500   PX211101_Person16_Age   
   https://www.phenxtoolkit.org   PX211101170500   PX211101_Person17_Age   
   https://www.phenxtoolkit.org   PX211101180500   PX211101_Person18_Age   
   https://www.phenxtoolkit.org   PX211101190500   PX211101_Person19_Age   
   https://www.phenxtoolkit.org   PX211101200500   PX211101_Person20_Age   
   https://www.phenxtoolkit.org   PX810501030000   PX810501_NTerminalProBrainNatriureticPeptide_NTProBNP_Age   
   https://www.phenxtoolkit.org   PX810601030000   PX810601_Reticulocyte_Age   
   https://www.phenxtoolkit.org   PX810901030000   PX810901_Billirubin_Age   
   https://www.phenxtoolkit.org   PX811001030000   PX811001_Lactate_Dehydrogenase_Age   
   https://www.phenxtoolkit.org   PX811201030000   PX811201_Aspartate_Aminotransferase_Age   
   https://www.phenxtoolkit.org   PX840201020000   PX840201_PediatricSchool_Performance_Current_Age   

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 6/26/2019 2:22:02 PM
  Attachment Units Required: N
  Long Common Name: Age
  Shortname: Age
  Fully Specified Name: Age: Time: Pt: ^Patient: Qn:
     
  Component Word Count: 1
  ID: 22414
  Status (Raw): ACTIVE


78894-3   Liver fibrosis score in Serum or Plasma Calculated by HepaScoreLiver fibrosis score in Serum or Plasma Calculated by HepaScoreLiver fibrosis score: Score: Pt: Ser/​Plas: Qn: Calculated.HepaScore  

NAME
  Fully Specified Name: 
Component   Property   Time   System   Scale   Method
Liver fibrosis score  Score  Pt  Ser/Plas  Qn  Calculated.HepaScore
  Long Common Name:  Liver fibrosis score in Serum or Plasma Calculated by HepaScore
  Short Name:  Liver fibr score SerPl Calc HepaScore
  Display Name:  Liver fibrosis score Calculated by HepaScore [Score]

TERM DEFINITION/DESCRIPTION(S)
  This term was created for the HepaScore liver fibrosis test, which is a marker of liver fibrosis in patients with hepatitis C infection. The score ranges from 0 to 1 and is calculated based on four lab tests (GGT, bilirubin, alpha-2-macroglobulin, and hyaluronic acid) plus the patient's age and gender. The HepaScore is reported with a central cut-off of 0.50, with a value ≥ 0.50 indicating that significant liver fibrosis is present (positive predictive value 88%) and a value < 0.50 indicating that advanced fibrosis is absent (negative predictive value 95%) for patients with hepatitis C infection. The HepaScore logistic regression model is as follows: y = exp[-4.185818 - (0.0249 x age) + (0.7464 x sex) + (1.0039 x α2-macroglobulin) + (0.0302 x hyaluronic acid) + (0.0691 x bilirubin) - (0.0012 x GGT)]
with age provided in years, male sex = 1, female sex = 0, α2-macroglobulin in g/L, hyaluronate in μg/L, bilirubin in μmol/L, and GGT in U/L. The score itself is calculated as y/(1 +y). [PMID: 16055434]
 
 

PART DEFINITION/DESCRIPTION(S)
  Part: Liver fibrosis score
  A liver fibrosis score is a noninvasive method used to determine the presence and degree of liver fibrosis in a patient based on a variety of different parameters (e.g., lab tests, age, and gender) depending on the method used. [PMID: 21254180] . Different methods used to calculate a patient 's liver fibrosis score include the Enhanced Liver Fibrosis (ELF) test, nonalcoholic fatty liver disease (NAFLD) fibrosis score, HepaScore, FibroMeter, and FibroSURE.
 
 

OBSERVATION REQUIRED IN PANEL
Required

BASIC ATTRIBUTES
  Class/Type: CHEM/Lab
  First Released in Version: 2.54
  Last Updated in Version: 2.54
  Order vs. Obs.: Both
  Status: Active

FORMULA -- READABLE
HepaScore = y/(1+y), where y = exp[-4.185818 - (0.0249 x age) + (0.7464 x sex) + (1.0039 x α2-macroglobulin) + (0.0302 x hyaluronic acid) + (0.0691 x bilirubin) - (0.0012 x GGT)]

MEMBER OF THESE PANELS     
  This section provides information about panels that contain this LOINC code.
  LOINC   Long Common Name  
  78698-8 Liver fibrosis score panel - Serum or Plasma Calculated by HepaScore
  

MEMBER OF THESE EQUIVALENCE GROUPS
  LG19496-5  Liver fibrosis score|Score|Pt|ANYBldSerPl

PARTS

Part Type    Part No.  Part Name   
Component   LP193274-0  Liver fibrosis score 
Property   LP185820-0  Score 
Time   LP6960-1  Pt   [Point in time (spot)] 
System   LP7576-4  Ser/Plas   [Serum or Plasma] 
Scale   LP7753-9  Qn 
Method   LP199510-1  Calculated.HepaScore   [Calculated by HepaScore] 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  肝纤维化评分:评分:时间点:血清/​血浆:定量型:计算法.HepaScore肝纤维化评分:评分:时间点:血清/​血浆:定量型:计算法.HepaScore
  French (FRANCE)  (From: ASIP Santé (Agence des systèmes d'information partagés de santé))
 
  Liver fibrosis score:Score:Pt:Ser/​Plas:Qn:Calculated.HepaScoreLiver fibrosis score:Score:Pt:Ser/​Plas:Qn:Calculated.HepaScoreScore de fibrose du foie [Score] Sérum/​Plasma ; Numérique ; Calcul par Hepascore
  Italian (ITALY)  (From: Regenstrief-generated full translation based on part translation provided by Consiglio Nazionale delle Ricerche)
 
  Fibrosi epatica, punteggio:Punteggio:Pt:Siero/​Plasma:Qn:Calcolato.HepaScoreFibrosi epatica, punteggio:Punteggio:Pt:Siero/​Plasma:Qn:Calcolato.HepaScore
  Spanish (SPAIN)  (From: Regenstrief-generated full translation based on part translation provided by the Clinical Laboratory Committee of SERVICIO EXTREMEÑO DE SALUD, with the support of BITAC MAP.)
 
  Puntuación fibrosis hepática:Puntuación:Punto temporal:Suero o Plasma:Qn:Calculado por HepaScorePuntuación fibrosis hepática:Puntuación:Punto temporal:Suero o Plasma:Qn:Calculado por HepaScore

RELATED NAMES
  Calc Point in time SerPl
  Calc.HepaScore QNT SerPlas
  Calculation Quan Serum
  Chemistry Quant Serum or plasma
  Liver fibr score Quantitative SR
  Pl Random  
  Plasma Scale  
  Plsm SerP  

EXAMPLE UNITS
  Unit  Source Type
  {score}  EXAMPLE UCUM UNITS 

UNITS (INTERNAL DETAILS)
  Source Type:  EXAMPLE UCUM UNITS 
  Unit:  {score} 

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 6/26/2019 2:22:02 PM
  Long Common Name: Liver fibrosis score in Serum or Plasma Calculated by HepaScore
  Shortname: Liver fibr score SerPl Calc HepaScore
  Fully Specified Name: Liver fibrosis score: Score: Pt: Ser/Plas: Qn: Calculated.HepaScore
     
  Component Word Count: 3
  ID: 82653
  Status (Raw): ACTIVE